The Fort Worth Press - Percept Corporation Announces Patented MiOptics Therapeutic Optics Now Available Through the Top Independent Optical Labs in North America

USD -
AED 3.67315
AFN 63.503991
ALL 83.375041
AMD 377.180403
ANG 1.790083
AOA 917.000367
ARS 1383.990604
AUD 1.452433
AWG 1.8
AZN 1.70397
BAM 1.69972
BBD 2.014322
BDT 122.712716
BGN 1.709309
BHD 0.377349
BIF 2968.5
BMD 1
BND 1.28787
BOB 6.936019
BRL 5.255304
BSD 1.000117
BTN 94.794201
BWP 13.787919
BYN 2.976987
BYR 19600
BZD 2.011341
CAD 1.38995
CDF 2282.50392
CHF 0.798523
CLF 0.023433
CLP 925.260396
CNY 6.91185
CNH 6.92017
COP 3680.29
CRC 464.427092
CUC 1
CUP 26.5
CVE 96.12504
CZK 21.309304
DJF 177.720393
DKK 6.492704
DOP 59.72504
DZD 133.275765
EGP 52.642155
ERN 15
ETB 156.62504
EUR 0.866104
FJD 2.260391
FKP 0.75231
GBP 0.75375
GEL 2.680391
GGP 0.75231
GHS 10.97039
GIP 0.75231
GMD 73.503851
GNF 8780.000355
GTQ 7.653901
GYD 209.354875
HKD 7.82605
HNL 26.510388
HRK 6.545204
HTG 131.099243
HUF 338.020388
IDR 16990.8
ILS 3.13762
IMP 0.75231
INR 94.864204
IQD 1310
IRR 1313250.000352
ISK 124.760386
JEP 0.75231
JMD 157.422697
JOD 0.70904
JPY 160.29904
KES 129.903801
KGS 87.450384
KHR 4012.00035
KMF 428.00035
KPW 899.886996
KRW 1508.00035
KWD 0.30791
KYD 0.833446
KZT 483.490125
LAK 21900.000349
LBP 89550.000349
LKR 315.037957
LRD 183.625039
LSL 17.160381
LTL 2.95274
LVL 0.60489
LYD 6.375039
MAD 9.344504
MDL 17.566669
MGA 4175.000347
MKD 53.384435
MMK 2102.490525
MNT 3571.507434
MOP 8.069509
MRU 40.120379
MUR 46.770378
MVR 15.450378
MWK 1737.000345
MXN 18.121104
MYR 3.924039
MZN 63.950377
NAD 17.160377
NGN 1383.460377
NIO 36.720377
NOK 9.70286
NPR 151.667079
NZD 1.740645
OMR 0.385081
PAB 1.000109
PEN 3.459504
PGK 4.309039
PHP 60.550375
PKR 279.203701
PLN 3.72275
PYG 6538.855961
QAR 3.65325
RON 4.427304
RSD 101.818038
RUB 81.419514
RWF 1461
SAR 3.752351
SBD 8.042037
SCR 14.429246
SDG 601.000339
SEK 9.47367
SGD 1.292804
SHP 0.750259
SLE 24.550371
SLL 20969.510825
SOS 571.503662
SRD 37.601038
STD 20697.981008
STN 21.35
SVC 8.75063
SYP 111.824334
SZL 17.160369
THB 32.860369
TJS 9.556069
TMT 3.5
TND 2.926038
TOP 2.40776
TRY 44.433404
TTD 6.795201
TWD 32.044404
TZS 2576.487038
UAH 43.837189
UGX 3725.687866
UYU 40.481115
UZS 12205.000334
VES 467.928355
VND 26337.5
VUV 119.756335
WST 2.77551
XAF 570.070221
XAG 0.014291
XAU 0.000222
XCD 2.70255
XCG 1.802452
XDR 0.706792
XOF 568.000332
XPF 104.103591
YER 238.603589
ZAR 17.119995
ZMK 9001.203584
ZMW 18.826586
ZWL 321.999592
  • RBGPF

    -13.5000

    69

    -19.57%

  • NGG

    -0.4800

    81.92

    -0.59%

  • RELX

    -0.1000

    31.97

    -0.31%

  • BCE

    -0.2200

    25.25

    -0.87%

  • CMSC

    -0.0500

    22.77

    -0.22%

  • RYCEF

    -0.5900

    14.65

    -4.03%

  • BTI

    0.3749

    57.8

    +0.65%

  • GSK

    -0.1000

    53.84

    -0.19%

  • RIO

    0.8500

    86.64

    +0.98%

  • AZN

    5.0200

    188.42

    +2.66%

  • CMSD

    -0.0900

    22.66

    -0.4%

  • BCC

    0.1400

    74.43

    +0.19%

  • VOD

    -0.1400

    14.49

    -0.97%

  • JRI

    -0.2700

    11.8

    -2.29%

  • BP

    0.5100

    46.68

    +1.09%

Percept Corporation Announces Patented MiOptics Therapeutic Optics Now Available Through the Top Independent Optical Labs in North America
Percept Corporation Announces Patented MiOptics Therapeutic Optics Now Available Through the Top Independent Optical Labs in North America

Percept Corporation Announces Patented MiOptics Therapeutic Optics Now Available Through the Top Independent Optical Labs in North America

Authorized Qualified Optical Labs include Cherry Optical, Complete Optical, OnSight Optical, Laramy-K Optical Lab, Pacific Artisan Labs and Plastic Plus.

Text size:

Authorized Qualified Optical Labs include Cherry Optical, Complete Optical, OnSight Optical, Laramy-K Optical Lab, Pacific Artisan Labs and Plastic Plus.

LAS VEGAS, NV / ACCESS Newswire / September 15, 2025 / Percept Corporation, a pioneer in advanced visual perception optics, AI and systems, announces MiOptics™ therapeutic optics are now available to eye care professionals (ECPs) and patients in North America through a network of Authorized Qualified MiOptics Optical Labs. They include Cherry Optical, Complete Optical, OnSight Optical, Laramy-K, Pacific Artisan Labs and Plastic Plus, which also serves as MiOptics' authorized Canadian distributor. Patented MiOptics True Narrow-Band Green Light (nbGL) optics are now available in plano and prescription through these authorized labs in patented nbGL formulation for base 2, base 4, base 6 and base 8 plano and r/x optical blanks which translate into a complete product offering for ECPs and patients needing the relief that MiOptics can bring, especially to chronic patient conditions.

MiOptics utilizes Percept Corporation's patented Augmented Perception™ technology, which mitigates disruptive color wavelengths in naturally occurring light. By allowing only narrow-band green light (nbGL) to reach the eyes, the nbGL technology behind MiOptics has been clinically shown to help alleviate migraines, headaches, anxiety/PTSD-related symptoms, sleep issues, vertigo, nausea/motion sickness and other neurological conditions-all without the need for medications. This breakthrough of nbGL has been validated in over 15 independent clinical studies, published in leading peer-reviewed journals such as BRAIN, Journal of Neurology, Psychology Research and Behavior Management, and The Journal of Pain. "This technology has the potential to help patients affected by migraine, photophobia, anxiety and sleep difficulties," said world-renowned Harvard neuroscientist and current president of the International Headache Society Dr. Rami Burstein, Ph.D., a Percept Corporation advisor who pioneered the research behind nbGL.

The Multitherapeutic Benefits of MiOptics

Percept Corporation spent over eight years of development and two years validating the combined value of nbGL bandwidth control and patients' prescriptive needs to achieve Optimized nbGL, which is incorporated in the patented MiOptics plano and r/x optical blanks. This allows Percept Corporation's Qualified MiOptics Optical Lab Network to make nearly every lens required by ECPs and their patients including plano, single vision, progressive/multifocal, computer vision and prism-based r/x lenses. It is the combination of the best optical blanks, the expertise of MiOptics ECPs and the state-of-the-art optical equipment and skills of MiOptics Qualified Labs.

As expressed by internationally renowned ECP Dr. Mile Brujic, "this is a game changer for the ECPs who need to help chronic patient conditions and is a fine complement to existing therapeutic optical products." Dr. Charles Shidlofsky, former NORA President and ECP, added, "MiOptics has been successful when used to help my severe neurological patients including TBI/concussion, PTSD and surprisingly, even visual snow." Dr. Scott Lewis, CEO and founder of Percept Corporation added, "the issues that over 40 million civilians and our veterans face include chronic migraines and headaches. The 70-100M+ patients with chronic anxiety disorders and PTSD alone represent almost half of the population."

MiOptics nbGL is the only technology with multiple clinically published results that helps reduce the intensity and frequency of chronic migraines and headaches-and it is the only optical nbGL treatment in the world of vision products for anxiety/PTSD demonstrated by multiple nbGL clinical studies published by scientists from Harvard and other institutions."

Optical Labs Owner Experiences with MiOptics

Adam Cherry, CEO of Cherry Optical, producer of each of the other therapeutic optical products on the market, put it this way, "MiOptics fills a market void where chronic condition patients need help not provided by other approaches."

This was further emphasized by Brandon Butler, CEO of Pacific Artisan Labs, who said, "it is great to be able to respond to the demand for MiOptics from our ECPs and to make almost every type of r/x lens with our advanced lab equipment. MiOptics are easy to work with Optimized nbGL plano and r/x blanks."

Paul and Jason Fabish, owners of Canada's largest independent optical lab, said, "MiOptics is a great addition to our range of optical solutions and fits a definite need for the Canadian and U.S. markets." Jason added, "my wife suffers from migraines, tried all of the other products and found that only MiOptics helped reduce her headaches. She keeps her MiOptics with her all the time now!"

Michael Shane, CEO of OnSight Optical added, "since the first optical job I did with MiOptics I was impressed by the ease of use. One of our first pair of MiOptics was for our lab manager who has chronic migraines. He tried the other available products without success, and within a few minutes of wearing his MiOptics r/x glasses he had significant relief. He wears them all the time now for his chronic migraine treatment management."

Janet Benjamin, co-owner of Laramy-K Optical Labwith son Keith, witnessed "the demand for a better optical approach for chronic migraines."

Dr. Mark Kahrhoff, a leading neuro-optometrist and owner of Complete Optical Labs, which is a MiOptics Qualified Lab and Authorized Distributor, commented, "MiOptics has helped patients who received no benefits from other products. One patient with chronic anxiety and TBI/concussions put it clearly that, 'this has changed my life.'"

To learn more about MiOptics and its benefits, please visit www.perceptcorp.com and the forthcoming www.MiOptics.shop where a complete directory of MiOptics Qualified ECPs can be found.

About Percept Corporation

Percept Corporation is an eleven-year-old privately held company that is a leader in technology, products, software and app solutions. Each innovation is designed to improve human perception while increasing performance, productivity, safety and individualized style. Based in Las Vegas, Percept Corporation has staff throughout the United States and Italy, in addition to partners in Europe and Asia. The intellectual property base of Percept Corporation includes licenses for over 47 U.S., European and Chinese patents. Percept Corporation is the only vision technology company in the world with a network of over 400 global advisors that includes vision experts and top advisors with direct veteran experience that includes Brigadier General Michael Meese (U.S. Army, ret.) and Secretary Anthony Principi, Secretary of the VA during the Bush administration. Percept Corporation is also the only vision technology company ever to be a Diamond Sponsor of the American Headache Society and a Corporate Roundtable Member of the International Headache Society along large pharma companies as Lilly, Pfizer and AbbVie.

This news release contains forward-looking statements as that term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934.

Media Contact
Krista Cain
(702) 952-5000
[email protected]

Percept Corporation
Krista Cain
(702) 952-5000
[email protected]

END

SOURCE: Percept Corporation



View the original press release on ACCESS Newswire

A.Williams--TFWP